Homeopathy 2010; 99(03): 183-188
DOI: 10.1016/j.homp.2010.05.001
Original Paper
Copyright © The Faculty of Homeopathy 2010

Preliminary investigation of metal and metalloid contamination of homeopathic products marketed in Croatia

Hrvoje Tumir
1   Agency for Medicinal Products and Medical Devices, Ksaverska cesta 4, 10000 Zagreb, Croatia
,
Jasna Bošnir
2   Andrija Štampar Institute of Public Health, Mirogojska 16, 10000 Zagreb, Croatia
,
Irena Vedrina-Dragojević
3   Faculty of Pharmacy and Biochemistry, University of Zagreb, Ante Kovačića 1, 10000 Zagreb, Croatia
,
Zrinka Dragun
4   Ruđer Bošković Institute, Division for Marine and Environmental Research, Bijenička c. 54, 10002 Zagreb, Croatia
,
Siniša Tomić
1   Agency for Medicinal Products and Medical Devices, Ksaverska cesta 4, 10000 Zagreb, Croatia
,
Dinko Puntarić
2   Andrija Štampar Institute of Public Health, Mirogojska 16, 10000 Zagreb, Croatia
› Author Affiliations

Subject Editor:
Further Information

Publication History

Received11 October 2009
revised10 April 2010

accepted17 May 2010

Publication Date:
17 December 2017 (online)

Background: Due to their popularity as a complementary therapy in many diseases, homeopathic products of animal, vegetable, mineral and chemical origin should be tested for the presence of contaminants to prevent eventual toxic effects.

Objective: Thirty samples of homeopathic products were analyzed to estimate possible contamination with potentially toxic elements: Pb, Cd, As, Hg, Cr, Ni and Zn, and to assess human exposure to these metals/metalloid as a consequence of their consumption.

Methods: Atomic absorption spectrometry was used to determine metal and metalloid concentrations.

Results: Most tested products had very low metal/metalloid levels (below the limit of quantification of the method), but the metal/metalloid levels in the remaining products were in the following ranges (in μgg−1): Pb 0.33–1.29 (6 samples), Cd 2.78 (1 sample), As 0.22 (1 sample), Hg 0.02–0.12 (24 samples), Cr 0.40–10.27 (10 samples), Ni 0.43–55.00 (19 samples), and Zn 2.20–27.80 (11 samples). In the absence of regulatory standards for homeopathic products, the obtained results were compared to maximum allowable levels (MALs) as proposed by USP Ad Hoc Advisory Panel. Some analyzed preparations had metal levels above MALs (Pb: 2 samples; Cd: 1 sample; Ni: 2 samples). However, estimated cumulative daily intakes from tested homeopathic products were in all cases lower than permitted daily exposures for all dosage forms.

Conclusion: The risk of bioaccumulation of metals/metalloid from the homeopathic medicines seems to be rather low, due to small quantities of those products prescribed to be applied per day, as well as insignificant metal contamination of the majority of tested products. However, the fact that particular formulations were contaminated by metals above MALs indicates potential risk and points to the necessity of regular monitoring of homeopathic products for metal contamination, due to their frequent and mostly unsupervised use.

 
  • References

  • 1 Schüppel R. Die Stellung der Homöopathie in der heutigen Medizin; Grundlagen der Homöopathie. Homöopathie im Blickpunkt. Karlsruhe, Germany: Deutsche Homöopathie-Union; 1994. pp 11–28; pp 74–78 (chapters 2; 5).
  • 2 Kleijnen J., Knipschild P., Riet G. Clinical trials of homeopathy. BMJ 1991; 302: 316-323.
  • 3 Cucherat M., Haugh M.C., Gooch M., Boissel J.P. Evidence of clinical efficacy of homeopathy. Eur J Clin Pharmacol 2000; 56: 27-33.
  • 4 Reilly D.T., Taylor M.A., Taylor M.A. et al. Is evidence for homeopathy reproducible?. Lancet 1994; 344: 1601-1606.
  • 5 Linde K., Clausius N., Ramirez G. et al. Are the clinical effects of homeopathy placebo effects? A meta analysis of placebo-controlled trials. Lancet 1997; 350: 834-843.
  • 6 Driehsen H.W., Foxman E.L., Hebisch C., Heger M., Hockenjos Zogg S., Stock W. Preamble. Editing Committee: European American Coalition on Homeopathy. Homeotherapy definitions and therapeutic schools. 1st edn. Hügelsheim: Offsetdrückerei GmbH Naber; 1997. p 12.
  • 7 Report on EMEA Workshop on Homeopathic Medicinal Products, London, 27th October 2006.
  • 8 European Pharmacopoeia 6.0. 2007; 1: 1063–1084.
  • 9 USP Advisory Panel on Metal Impurities. Rockville, April 2009. Available from: http://www.usp.org/pdf/EN/hottopics/2009-04-22MetalImpuritiesToxChart.pdf (accessed September 2009).
  • 10 Kučak A., Blanuša M. Validation of microwave digestion method for determination of trace elements in mushrooms. Arch Ind Hyg Toxicol 1998; 49 (04) 335-342.
  • 11 Beaty R.D., Kerber J.D. Concepts, instrumentation and techniques in atomic absorption spectrophotometry. Norwalk, CT: Perkin–Elmer Corporation; 1993.
  • 12 Perkin–Elmer. Flow injection mercury/hydride analysis: recommended analytical conditions and general information. Perkin–Elmer Corporation, Bodenseewerk; 1992.
  • 13 Perkin–Elmer. User’s guide: atomic absorption. Norwalk, CT: Perkin–Elmer Corporation; 1992.
  • 14 FAPAS. Proficiency Test 0761 Report. Metallic contaminants in powder milk, 2005.
  • 15 FAPAS. Proficiency Test 0769 Report. Metallic contaminants in soft drink, 2006.
  • 16 FAPAS. Proficiency Test 0783 Report. Metallic contaminants in soft drinks, 2007.
  • 17 FAPAS. Proficiency Test 0795 Report. Metallic contaminants in soft drinks, 2007.
  • 18 IFA TULLN. Proficiency testing scheme for water analysis. Metals, Final Report M74, 2006.
  • 19 Tumir H., Bošnir J., Vedrina-Dragojević I. et al. Monitoring of metal and metalloid content in dietary supplements on the Croatian market. Food Control 2010; 21 (06) 885-889.
  • 20 Guédon D., Brum M., Seigneuret J.M. et al. Impurities in herbal substances, herbal preparations and herbal medicinal products, IV. Heavy (toxic) metals. Nat Prod Commun 2008; 3 (12) 2107-2122.
  • 21 Garvey G.J., Hahn G., Lee R.V., Harbison R.D. Asian traditional remedies. Int J Environ Health Res 2001; 11: 63-71.
  • 22 Obi E., Akunyili D.N., Ekpo B., Orisakwe O.E. Heavy metal hazard of Nigerian herbal remedies. Sci Total Environ 2006; 369: 35-41.
  • 23 Koh H.L., Woo S.O. Chinese proprietary medicine in Singapore. Drug Saf 2000; 23 (05) 351-362.
  • 24 European Medicines Agency. Committee for medicinal products for human use. Guideline on the specification limits for residues of metal catalysts or metal reagents London . February 2008. Available from: http://www.emea.europa.eu/pdfs/human/swp/444600enfin.pdf (accessed September 2009)